京基智農(000048.SZ)擬通過廣東京基智農向4家孫公司增資建設生豬養殖產業鏈項目
格隆匯12月15日丨京基智農(000048.SZ)公佈,公司擬投資建設徐聞、高州、賀州、文昌等生豬養殖產業鏈項目,以各地全資孫公司作為項目實施主體。
為滿足經營發展需要,提升全資孫公司的綜合實力,優化資本結構,加快推進生豬養殖產業鏈項目的落地,公司擬通過全資子公司廣東京基智農對全資孫公司(徐聞、高州、賀州、文昌)增資(擬分別增資6.9億元、3.1億元、2.4億元、2.3億元),增資金額在前述各生豬養殖產業鏈項目投資金額範圍之內。本次增資資金主要用於生豬養殖產業鏈項目建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.